Cedric Loiret-Bernal, Deborah Neff, Michael Kranda, Robert Ellis, Colin Brenan, Terrance Bieker, Len Hendrickson, Robert Weltman, Robert Rosenthal, John Canepa | GenomeWeb

Cedric Loiret-Bernal has become the president and CEO of Nanolink, a Chicago-based company that makes nanofabricated devices. Loire-Bernal was previously CEO of Geneva Proteomics, which he co-founded. He most recently held a position at CDP Capital Technology Ventures, a Canadian investment company. Prior to founding GeneProt, Loiret-Bernal was a partner and senior investment analyst at Brinson Partners, now part of UBS. He holds a medical degree from the University of Bordeaux and an MBA from Northwestern University.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.